Nanki, T.; Kawazoe, M.; Uno, K.; Hirose, W.; Dobashi, H.; Kataoka, H.; Mimura, T.; Hagino, H.; Kono, H.
Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial. J. Clin. Med. 2023, 12, 292.
https://doi.org/10.3390/jcm12010292
AMA Style
Nanki T, Kawazoe M, Uno K, Hirose W, Dobashi H, Kataoka H, Mimura T, Hagino H, Kono H.
Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial. Journal of Clinical Medicine. 2023; 12(1):292.
https://doi.org/10.3390/jcm12010292
Chicago/Turabian Style
Nanki, Toshihiro, Mai Kawazoe, Kiyoko Uno, Wataru Hirose, Hiroaki Dobashi, Hiroshi Kataoka, Toshihide Mimura, Hiroshi Hagino, and Hajime Kono.
2023. "Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial" Journal of Clinical Medicine 12, no. 1: 292.
https://doi.org/10.3390/jcm12010292
APA Style
Nanki, T., Kawazoe, M., Uno, K., Hirose, W., Dobashi, H., Kataoka, H., Mimura, T., Hagino, H., & Kono, H.
(2023). Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial. Journal of Clinical Medicine, 12(1), 292.
https://doi.org/10.3390/jcm12010292